Ursal, Jeraldin G.
HRN: 24-24-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/15/2023
12/22/2023
IV
600mg
Q8H
Infected Wound, L Hand
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes